Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus-Reference-Cited by-同舟云学术

Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus

Published:1998-10 Issue:9138 Volume:352 Page:1426-1432
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Poynard Thierry,Marcellin Patrick,Lee Samuel S,Niederau Christian,Minuk Gerald S,Ideo Gaetano,Bain Vincent,Heathcote Jenny,Zeuzem Stefan,Trepo Christian,Albrecht Janice

Publisher

Elsevier BV

Subject

General Medicine

Reference27 articles.

1. Epidemiology of hepatitis C;Alter;Hepatology,1997

2. Hepatitis C: global prevalence:;Wkly Epidemiol Rec,1997

3. Long-term mortality after transfusion-associated non-A non-B hepatitis;Seeff;New Engl J Med,1992

4. Clinical outcomes after transfusion-associated hepatitis C;Tong;N Engl J Med,1995

5. Natural history of liver fibrosis progression in patients with chronic hepatitis C;Poynard;Lancet,1997

Cited by 2096 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A statistical method for removing unbalanced trials with multiple covariates in meta-analysis;PLOS ONE;2023-12-15

2. Hepatitis C Virus (HCV) and the Role of Phytochemicals in the Anti-Viral Effects of Different Medicinal Plants Against Infection;Reference Series in Phytochemistry;2023-11-01

3. A Synopsis of Hepatitis C Virus Treatments and Future Perspectives;Current Issues in Molecular Biology;2023-10-11

4. Analysis of Short-Term and Long-Term Outcomes of Living Donor Liver Transplantation for Patients with a High Model for End-Stage Liver Disease Score;Transplantation Proceedings;2023-05

5. Chronic Hepatitis C;Medical Clinics of North America;2023-05